Nano-X Imaging (NASDAQ:NNOX) Upgraded by LADENBURG THALM/SH SH to Strong-Buy Rating

Nano-X Imaging (NASDAQ:NNOX) was upgraded by equities research analysts at LADENBURG THALM/SH SH to a “strong-buy” rating in a note issued to investors on Thursday,Zacks.com reports.

A number of other equities analysts have also recently issued reports on the stock. D. Boral Capital restated a “buy” rating and set a $8.00 target price on shares of Nano-X Imaging in a research report on Tuesday. Weiss Ratings restated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday. Finally, Alliance Global Partners upgraded Nano-X Imaging to a “strong-buy” rating in a report on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $8.50.

Nano-X Imaging Stock Performance

Nano-X Imaging stock opened at $4.36 on Thursday. Nano-X Imaging has a fifty-two week low of $2.78 and a fifty-two week high of $11.00. The firm has a market capitalization of $251.92 million, a price-to-earnings ratio of -4.84 and a beta of 1.97. The stock’s fifty day moving average is $3.74 and its two-hundred day moving average is $4.47.

Nano-X Imaging (NASDAQ:NNOX) last released its quarterly earnings results on Thursday, November 20th. The company reported ($0.65) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.47). Nano-X Imaging had a negative return on equity of 32.09% and a negative net margin of 468.29%.The firm had revenue of $3.45 million for the quarter, compared to analyst estimates of $3.51 million. Nano-X Imaging has set its FY 2026 guidance at EPS. As a group, sell-side analysts forecast that Nano-X Imaging will post -0.92 EPS for the current fiscal year.

Institutional Trading of Nano-X Imaging

Hedge funds have recently bought and sold shares of the company. CIBC Bancorp USA Inc. purchased a new stake in Nano-X Imaging in the 3rd quarter worth approximately $40,000. PharVision Advisers LLC acquired a new position in shares of Nano-X Imaging during the 3rd quarter valued at about $56,000. Virtu Financial LLC lifted its holdings in shares of Nano-X Imaging by 253.8% during the 3rd quarter. Virtu Financial LLC now owns 57,366 shares of the company’s stock worth $212,000 after acquiring an additional 41,150 shares during the period. UBS Group AG lifted its holdings in shares of Nano-X Imaging by 68.8% during the 3rd quarter. UBS Group AG now owns 1,086,645 shares of the company’s stock worth $4,021,000 after acquiring an additional 442,899 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in shares of Nano-X Imaging by 64.6% in the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after acquiring an additional 7,749 shares during the last quarter. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.